These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10520638)

  • 1. Retinoic acid for treatment of multicentric Castleman's disease.
    Rieu P; Droz D; Gessain A; Grünfeld JP; Hermine O
    Lancet; 1999 Oct; 354(9186):1262-3. PubMed ID: 10520638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multilocular Castleman's Disease of the mixed type. An rare differential diagnosis in lymphadenopathy with weakness, weight loss and night-sweats].
    Röhrig G; Engel H; Noack F; Ganser A; Peest D
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1070-2. PubMed ID: 11602914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
    Kingsmore SF; Silva OE; Hall BD; Sheldon EA; Cripe LD; St Clair EW
    J Rheumatol; 1993 Sep; 20(9):1588-91. PubMed ID: 8164221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?
    Kayasut K; Le Tourneau A; Rio B; Bost-Bezeaud F; Heuberger L; Diebold J; Audouin J
    Histopathology; 2006 Nov; 49(5):557-8. PubMed ID: 17064311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Castleman's disease. Discussion related to case report].
    Dănăilă C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):133-41. PubMed ID: 12089914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman's disease complicated by tumor lysis syndrome.
    Lee KD; Lee KW; Choi IS; Yoon SS; Park S; Kim BK; Kim NK
    Ann Hematol; 2004 Nov; 83(11):722-5. PubMed ID: 15316754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ganglionnar Hodgkin lymphoma associated to a Castleman's disease].
    Chelly I; Bellil S; Nfoussi H; Mekni A; Tangour M; Kilani H; Haouet S; Kchir N; Zitouna M
    Tunis Med; 2009 Sep; 87(9):639-40. PubMed ID: 20180391
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicentric hyaline-vascular Castleman's disease.
    Parker MS
    Clin Radiol; 2007 Jul; 62(7):707-10. PubMed ID: 17556043
    [No Abstract]   [Full Text] [Related]  

  • 9. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
    Nord JA; Karter D
    Int J STD AIDS; 2003 Jan; 14(1):61-2. PubMed ID: 12590797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of multicentric Castleman's disease treated with CEOD chemotherapy].
    Wang HH; Yao K; Li YC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):56-8. PubMed ID: 22575196
    [No Abstract]   [Full Text] [Related]  

  • 12. Castleman's disease with renal infiltration by polyclonal plasma cells.
    Frøkjaer Thomsen O; Ladefoged J
    Clin Nephrol; 1998 May; 49(5):328-30. PubMed ID: 9617500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature.
    O'Reilly PE; Joshi VV; Holbrook CT; Weisenburger DD
    Mod Pathol; 1993 Nov; 6(6):776-80. PubMed ID: 8302822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plasma cell variant of Castleman's disease treated successfully with cimetidine. Case report and review of the literature.
    Barbounis V; Efremidis A
    Anticancer Res; 1996; 16(1):545-7. PubMed ID: 8615669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
    Med Lett Drugs Ther; 2015 Jan; 57(1459):e8. PubMed ID: 25555075
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
    Wang X; Ye S; Xiong C; Gao J; Xiao C; Xing X
    Jpn J Clin Oncol; 2011 Oct; 41(10):1221-4. PubMed ID: 21890654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual presentation of hyaline vascular Castleman's disease.
    Kumar D; Rajni
    J Assoc Physicians India; 2008 Jul; 56():557-8. PubMed ID: 18846915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.